Citius Oncology (NASDAQ:CTOR - Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.09) earnings per share (EPS) for the quarter, Zacks reports.
Citius Oncology Price Performance
Shares of NASDAQ:CTOR traded down $0.04 during midday trading on Tuesday, hitting $1.21. The stock had a trading volume of 9,979 shares, compared to its average volume of 105,210. Citius Oncology has a 12 month low of $0.85 and a 12 month high of $49.00. The company has a current ratio of 0.34, a quick ratio of 0.08 and a debt-to-equity ratio of 0.08. The business has a 50-day moving average of $1.17.
Analysts Set New Price Targets
Separately, Maxim Group assumed coverage on shares of Citius Oncology in a research note on Wednesday, November 27th. They issued a "buy" rating and a $3.00 target price for the company.
Check Out Our Latest Research Report on CTOR
Citius Oncology Company Profile
(
Get Free Report)
Citius Oncology, Inc is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma.
Featured Articles
Before you consider Citius Oncology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Citius Oncology wasn't on the list.
While Citius Oncology currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
